Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) [Phase 3]
A Phase 3 trial in first-line extensive-stage small-cell lung cancer compares Tarlatamab plus Durvalumab with Carboplatin and Etoposide to D…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
This clinical trial update from the National Cancer Institute describes tissue procurement and a natural history study enrolling people with…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
A not-yet-recruiting trial from University of Kansas Medical Center aims to comprehensively map oncogenomic profiles in thoracic and head-an…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy [Phase 1]
Ongoing Phase 1 trial update for 225Ac-ABD147 to establish the optimal dose in patients with small-cell lung cancer and large cell neuroendo…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of DXC014 in Patients With Advanced Solid Tumors. [Phase 1]
Phase 1 study of the investigational drug DXC014 in advanced solid tumors is currently recruiting. It includes patients with small cell lung…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability [Phase 3]
Phase 3 trial evaluating whether high-dose radiation targeted to brain metastases with hippocampus-sparing approaches is better at preservin…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Lay Navigation Intervention for Patients With Lung Cancer [NA]
This clinical trial update describes a lay navigation intervention intended to support patients with lung cancer, including non-small cell a…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating sacituzumab govitecan with atezolizumab and durvalumab as maintenance therapy for extensive-stage small cell lung c…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC [Phase 2]
This is a Phase 2 trial evaluating nab-paclitaxel with local therapy for relapsed small cell lung cancer (extensive stage). The study status…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) [Phase 3]
Phase 3 clinical trial studying ZL-1310 versus investigator's choice of therapy in relapsed small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS) [Phase 2]
Phase 2 trial evaluating BMS-986489 (Atigotatug) in combination with Nivolumab versus Durvalumab in limited-stage small cell lung cancer; tr…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [Phase 3]
A Phase 3 clinical trial is investigating GSK5764227 in participants with relapsed small cell lung cancer, with recruitment currently ongoin…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer [Phase 1]
Phase 1 study of DSP-0390 in combination with atezolizumab for small cell lung cancer; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. [Phase 3]
Durvalumab is being studied after chemoradiotherapy in a Phase 3 trial for limited-stage small cell lung cancer, and the study is currently …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
NiKang Therapeutics is conducting a Phase 1 study of NKT3964 in adults with advanced or metastatic solid tumors, and the trial is currently …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer [Phase 1, Phase 2]
Ongoing Phase 1/2 trial update evaluating iadademstat in combination with atezolizumab or durvalumab for extensive-stage small cell lung can…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy [Phase 3]
Phase 3 trial (DAREON-Lung-1) evaluating Obrixtamig plus atezolizumab with carboplatin and etoposide versus standard chemotherapy in advance…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing [Phase 1]
Phase 1 clinical trial investigating therapeutic drug monitoring-based dosing of atezolizumab across multiple cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer [Phase 2, Phase 3]
Pfizer is conducting the Symbiotic-Lung-04 trial to evaluate PF-08634404 in combination with chemotherapy for adults with extensive-stage sm…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating SGN-CEACAM5C in adults with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer [Phase 2]
Pfizer is conducting a Phase 2 study of PF08634404 in combination with chemotherapy for transformed small cell lung cancer, and the trial is…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating Benmelstobart and Anlotinib in combination with chemotherapy and thoracic radiotherapy for extensive-stage…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4175408 in Participants With Advanced Cancer [Phase 1]
A Phase 1 clinical trial evaluating LY4175408 in participants with advanced cancers, including non-small cell lung cancer, small cell lung c…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma [Phase 1]
Pfizer is conducting a Phase 1 study of mevrometostat for relapsed/refractory small cell lung cancer, metastatic castration-resistant prosta…